(Q33729956)

English

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

object named as

Koon Teo

2

0 references

object named as

Irina Chazova

13

0 references

Craig S. Anderson

object named as

Craig Anderson

1

0 references

6

object named as

Thomas Unger

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

object named as

Janice Pogue

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Peggy Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hisatomi Arima

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Antonio Dans

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Patrick Commerford

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leanne Dyal

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Helmut Schumacher

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ernesto Paolasso

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nicolaas Holwerda

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Azan Binbrek

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

James Young

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ONTARGET and TRANSCEND Investigators

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

25 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

43-53

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for vascular dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular risk factors, incidence of MCI, and rates of progression to dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Silent brain infarcts and the risk of dementia and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging therapies for vascular dementia and vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Renin-angiotensin system and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970250-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(10)70250-7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33729956&oldid=1964968645"